Beijing Shenzhou Cell Biotechnology Group Co.
Latest round
- Series A
Last raised
- May 2017
Total raised
- $29M
Investors
- 1
About Beijing Shenzhou Cell Biotechnology Group Co.
, Ltd., Ltd. focuses on developing advanced cell-based treatments., Ltd. specializes in advanced cellular therapies, focusing on innovative solutions for various medical conditions. Their core product offerings include a range of cell-based treatments designed to enhance immune response and combat diseases such as cancer and autoimmune disorders. The company serves a diverse client base, including hospitals, research institutions, and healthcare providers, primarily in the Asia-Pacific region, with particular emphasis on markets such as China, Japan, and South Korea., Ltd. is built around strategic partnerships and direct business transactions with healthcare providers and institutions. Their business model incorporates B2B collaborations, allowing for integrated solutions that enhance patient care and treatment efficacy. Transactions typically involve long-term contracts or agreements that facilitate access to their flagship cell therapies, which may be offered at tiered pricing based on treatment complexity and patient needs. These arrangements ensure a steady revenue stream as healthcare providers adopt their innovative solutions for patient care., Ltd. plans to leverage the proceeds from its IPO in June 2020 to expand its product portfolio and geographic reach. The company is designing new cell-based therapies aimed at improving treatment efficacy for autoimmune diseases, with launches expected in the coming years. Additionally, they aim to penetrate new markets in Southeast Asia, particularly targeting Indonesia and Vietnam by 2023, to increase their market footprint and enhance their service offerings.
Who invested in Beijing Shenzhou Cell Biotechnology Group Co.
1 investor across 1 round
See all investors in Beijing Shenzhou Cell Biotechnology Group Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 1, 2017
Amount
$29M
Investors
Questions about Beijing Shenzhou Cell Biotechnology Group Co.
Who invested in Beijing Shenzhou Cell Biotechnology Group Co.?
Beijing Shenzhou Cell Biotechnology Group Co. has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beijing Shenzhou Cell Biotechnology Group Co. raised?
Beijing Shenzhou Cell Biotechnology Group Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Beijing Shenzhou Cell Biotechnology Group Co. last raise money?
Beijing Shenzhou Cell Biotechnology Group Co.'s most recent round on record is a Series A, in May 2017.
What does Beijing Shenzhou Cell Biotechnology Group Co. do?
Beijing Shenzhou Cell Biotechnology Group Co. is a biotechnology company.
Where is Beijing Shenzhou Cell Biotechnology Group Co. headquartered?
Beijing Shenzhou Cell Biotechnology Group Co. is headquartered in Beijing, China.
Which VCs invest in companies like Beijing Shenzhou Cell Biotechnology Group Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Beijing Shenzhou Cell Biotechnology Group Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Beijing Shenzhou Cell Biotechnology Group Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.